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Abstract 18 
β-Lactoglobulin hydrolysates (βlgHs) were generated using elastase at enzyme-to-substrate 19 
ratios (E:S) of 0.5, 1.0 and 1.5% in order to reach target degree of hydrolysis (DH) values of 20 
9 and 13%. The impact of different E:S during manufacture on hydrolysates having similar 21 
DHs was assessed. Samples with similar DHs generated with different E:S showed 22 
comparable molecular mass distribution profiles and in vitro dipeptidyl peptidase IV (DPP-23 
IV) inhibitory activities (p > 0.05). Liquid-chromatography tandem mass spectrometry (LC-24 
MS/MS) analysis showed that 62 and 84% of the peptides identified were common within 25 
hydrolysates having a similar DH of 9 or 13%, respectively. Differences in the peptides 26 
identified within hydrolysates having similar DHs may be due to E:S dependent 27 
modifications in specificity and enzyme kinetics. Overall, this study showed that reduction in 28 
E:S while targeting the development of a similar DH for βlgHs may be employed to reduce 29 
the cost of hydrolysate production without having an adverse impact on the bioactivity and 30 
physicochemical properties studied herein. 31 
 32 
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1 Introduction 36 
Whey proteins are highly valued for their functional and nutritional properties such as their 37 
ability to form stable foams and emulsions, their essential amino acid composition, ligand 38 
binding ability and the presence of bioactive peptides within their sequences (Cayot & 39 
Lorient, 1998; Le Maux, 2013; Smithers, 2008). Milk-derived bioactive peptides are of 40 
significant interest due to the potential health benefits associated with their antioxidant, 41 
antidiabetic and antihypertensive properties (Hernández-Ledesma, García-Nebot, Fernández-42 
Tomé, Amigo, & Recio, 2014; Korhonen & Pihlanto, 2006; Nongonierma & FitzGerald, 43 
2015; Nongonierma, O’Keeffe, & FitzGerald, 2016). 44 
β-Lactoglobulin (βlg), the major whey protein in bovine milk, is an important source of 45 
bioactive peptides (Hernández-Ledesma, Recio, & Amigo, 2008; Tulipano, Faggi, Nardone, 46 
Cocchi, & Caroli, 2015b). In mature bovine milk, βlg has a concentration of 3.2 g L-1 and 47 
represents about 50% of total whey proteins (i.e., about 10% of total milk proteins). 48 
Bioactive peptides can be released by enzymatic hydrolysis of food proteins. However, the 49 
peptides released, and consequently the hydrolysate properties, are highly dependent on the 50 
enzymatic processing conditions employed such as the specificity of the enzyme used, 51 
substrate concentration, pH, hydrolysis duration and incubation temperature (Cheison & 52 
Kulozik, 2017; Cheison, Schmitt, Leeb, Letzel, & Kulozik, 2010; Dixon & Webb, 1979; 53 
Mota et al., 2006; Spellman, O'Cuinn, & FitzGerald, 2005; Wei & Zhimin, 2006; Whitehurst 54 
& Law, 2002). It was previously shown that the peptides generated during enzymatic 55 
hydrolysis could differ or have different kinetics of release depending on reaction conditions. 56 
This was mostly attributed to changes in the enzyme/substrate conformation or due to 57 
differences in the accessibility of the enzyme to the substrate (Cheison, Lai, Leeb, & Kulozik, 58 
2011). 59 
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Estimation of the degree of hydrolysis (DH) is frequently used as a quality control parameter 60 
for food protein hydrolysates (Silvestre, 1997). However, the DH only provides information 61 
about the proportion of the peptide bonds hydrolysed but no information about the specific 62 
peptide bonds hydrolysed and therefore the peptide sequences generated. The cost of certain 63 
food-grade enzyme preparations can be as high as 1000 $ per kg (Hyun & Shin, 2000). One 64 
of the strategies which may be used to reduce processing costs during industrial batch 65 
enzymatic hydrolysis may be to decrease the enzyme-to-substrate ratio (E:S), while 66 
increasing the hydrolysis reaction duration in order to reach a target DH. In this case, DH is 67 
generally used as an indicator for the extent of the hydrolysis process. Nevertheless, to our 68 
knowledge, no published study has to date shown that similar peptides were released or that 69 
the bioactive properties of the hydrolysates were of the same order when hydrolysates were 70 
generated to a similar DH value while employing different E:S and durations of hydrolysis. 71 
The inhibition of dipeptidyl peptidase IV (DPP-IV) has been previously used as an in vitro 72 
indicator of an antidiabetic effect as inhibition of this enzyme can result in improved serum 73 
glucose regulation in type-2 diabetes (Juillerat-Jeanneret, 2014; Tulipano, Sibilia, Caroli, & 74 
Cocchi, 2011). Porcine elastase (EC 3.4.21.36) has previously been shown to release DPP-IV 75 
inhibitory peptides from -lactalbumin (la) (Nongonierma, Le Maux, Hamayon, & 76 
FitzGerald, 2016). Elastase is a broad-specificity serine protease, which cleaves peptide 77 
bonds at the carboxyl end of amino acids having small hydrophobic side chains such as Ala, 78 
Ile, Leu and Val (Bode, Meyer, & Powers, 1989; Godfrey, 1996). In the current study, 79 
elastase was chosen as a model proteinase based on an in silico analysis to hydrolyse βLg 80 
using three different E:S, with the objective of reaching two different target DH values. 81 
Subsequently, we compared the peptide composition and bioactive (DPP-IV inhibitory) 82 
properties of bovine βlg hydrolysates having similar DH values but which were generated 83 
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using different E:S. The physicochemical properties of the resulting βlg hydrolysates were 84 
then analysed with respect to their DH, molecular mass distribution and peptide profile. 85 
2 Materials and methods 86 
2.1 Reagents 87 
βLg ( 85% (w/w) purity, product number L2506), trifluoroacetic acid (TFA), 88 
tris(hydroxymethyl)aminomethane (TRIS), Gly-Pro-pNA, diprotin A (IPI), porcine DPP-IV 89 
(≥ 10 units mg-1 protein), mass spectrometry (MS) grade water and acetonitrile (MeCN) were 90 
obtained from Sigma Aldrich (Dublin, Ireland). 2,4,6-Trinitrobenzenesulfonic acid (TNBS) 91 
was obtained from Pierce Biotechnology (Medical Supply Company, Dublin, Ireland). 92 
Porcine elastase (1000 U g
-1
) was purchased from My Biosource (San Diego, CA, USA). All 93 
other chemicals were obtained from Sigma Aldrich and were of analytical grade unless 94 
otherwise stated. 95 
2.2 In silico digestion of βlg 96 
The in silico digestion of βlg variant A was carried out with a peptide cutter programme 97 
available on Matlab (version R2015b, MathWorks Inc., Natick, MA, USA), as previously 98 
described (Nongonierma, Le Maux, et al., 2016). Briefly, βlg variant A was digested in silico 99 
using cleavage rules for elastase, which consist in cleavage at the C-terminal side of Leu, Ala, 100 
Val, Ile Ser, Tyr and Thr (http://merops.sanger.ac.uk). The peptides predicted to be released 101 
by elastase were subsequently analysed to identify sequences presenting features of known 102 
DPP-IV inhibitory peptides. These features consists of an hydrophobic amino acid (Trp, Leu, 103 
Ile or Phe) at the N-terminus, a Pro/Ala at position 2, and a Pro at the C-terminus 104 
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(Nongonierma & FitzGerald, 2013b, 2014; Nongonierma & FitzGerald, 2016; Tulipano, 105 
Faggi, Nardone, Cocchi, & Caroli, 2015a). 106 
2.3 Enzymatic hydrolysis of βlg 107 
βLg (purity  85% (w/w)) was resuspended at 50 g L-1 in MS grade water and rehydrated at 108 
50ºC for 1 h under agitation. The pH of the solution was at 7.0. Porcine elastase was added to 109 
the solution at different E:S (0.5, 1.0 or 1.5% (w/w)). Preliminary studies assessed the change 110 
in DH as a function of incubation time during the hydrolysis of βlg with elastase at various 111 
E:S in order to reach target DH values of 9 and 13%. Hydrolysis was carried out at 50ºC 112 
under agitation for the durations described in Table 1. Hydrolysate samples were withdrawn 113 
and were diluted 1:1 with MS grade water (previously heated at 90ºC) immediately prior to 114 
enzyme inactivation by heating at 90ºC for 20 min in a water bath. The hydrolysates 115 
generated were then aliquoted and stored at -20ºC prior to further analysis. Each hydrolysis 116 
reaction was performed in triplicate (n=3). Samples were coded using their E:S and the DH 117 
value reached, i.e., βlgH-0.5-DH9 for a βlgH generated using an E:S of 0.5% (w/w) which 118 
had reached a DH of ~9% (see Table 1). 119 
2.4 Quantification of the DH using the TNBS method 120 
DH was quantified using the TNBS method adapted to a 96-well microplate as described by 121 
Le Maux, Nongonierma, Barre, and FitzGerald (2016), using a Biotek Synergy HT 122 
(Winoosky, VT, USA) plate reader. Leucine was used as a standard to allow determination of 123 
the free amino group content of the samples (AN, in mg –NH2 mg
-1
 sample). DH was 124 
calculated using the following formula: 125 
% 𝐷𝐻 =  
𝐴𝑁𝑠𝑎𝑚𝑝𝑙𝑒 − 𝐴𝑁𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑁𝑝𝑏
× 100 
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A value of 123.3 mg g
-1
 was used as the amino group content of the peptide bonds (Npb) 126 
(Adler-Nissen, 1986). Each sample was analysed in triplicate (n=3). 127 
2.5 Molecular mass distribution by gel permeation chromatography 128 
Gel permeation ultra-performance liquid chromatography (GP-UPLC) monitored at 214 nm 129 
was used to determine the molecular mass distribution of the hydrolysates. Samples were 130 
analysed using an Acquity UPLC system equipped with an Acquity BEH125 SEC column 131 
(4.6 × 150 mm, 1.7 µm) and an Acquity BEH125 SEC 1.7 μm vanguard pre-column, all from 132 
Waters (Milford, MA, USA). Samples (protein equivalent content of 0.02 mg) were eluted 133 
using 30% (v/v) MeCN containing 0.1% (v/v) TFA at a flow rate of 0.3 mL min
-1
 for 8 min at 134 
room temperature (~20ºC). The molecular masses of the different compounds within the 135 
sample were determined using molecular mass standards (i.e., bovine serum albumin (BSA), 136 
βLg, La, aprotinin, bacitracin, Leu-Trp-Met-Arg, Asp-Glu and Tyr) ranging from 67,500 to 137 
181 Da. Results were expressed as the proportion of the peak area within different molecular 138 
mass ranges: < 1 kDa, 1-5 kDa, 5-10 kDa and > 10 kDa. 139 
2.6 Peptide detection using hydrophilic interaction liquid chromatography-mass 140 
spectrometry (HILIC-MS) 141 
Samples were analysed by HILIC-MS using an Acquity UPLC system (Waters) coupled to a 142 
quadrupole time-of-flight MS (Q-TOF, Impact HD™, Bruker Daltonics GmbH, Bremen, 143 
Germany). The MS was equipped with an electrospray ionisation (ESI) source used in 144 
positive ion mode. Instrument control and data acquisition were performed using Hystar™ 145 
software (Bruker Daltonics). The UPLC system was equipped with a tunable UV detector set 146 
at 214 and 280 nm. 147 
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Samples were analysed using a method previously described and validated by Le Maux, 148 
Nongonierma, and FitzGerald (2015), with some modifications. Briefly, HILIC-UPLC was 149 
performed on an Acquity BEH Amide column (2.1 × 150 mm, 1.7 μm, 130 Å) equipped with 150 
an Acquity BEH Amide 1.7 μm vanguard pre-column, both from Waters. A linear gradient 151 
from 97 to 65% (v/v) MeCN, containing 0.1% (v/v) TFA, was applied for 60 min at a flow 152 
rate of 0.2 mL min
-1
. Samples (25 µg) were injected onto the column. The column 153 
temperature was maintained at 40ºC. MS measurements were performed over a 100-2200 m/z 154 
acquisition range. 155 
MS data were processed on PEAKS 7.5 (Bioinformatics Solutions Inc., Waterloo, Ontario, 156 
Canada). Peptides were identified using an in-house milk protein database composed of the 157 
main bovine milk proteins (βlg, αla, BSA, lactoferrin, αs1-, αs2-, β- and κ-casein) as given in 158 
Uniprot (http://www.uniprot.org/uniprot/). The database search used was specified as 159 
follows: data were refined using error tolerances of 15 ppm and 0.5 Da for precursor mass 160 
and fragment ion, respectively. A non-specific enzyme cleavage was selected, oxidation of 161 
Met and phosphorylation of Ser, Thr and Tyr were set as variable modifications. The results 162 
were filtered using the following parameters: a 50% de novo threshold (average local 163 
confidence score, ALC) and a 0.1% false discovery rate (FDR). Only de novo peptides that 164 
fully matched bovine milk protein sequences were considered valid for peptide identification. 165 
The data from hydrolysate triplicates were pooled and considered as one sample by PEAKS. 166 
Comparison of samples having the same DH but different E:S was achieved with PEAKS 167 
using the “comparison PEAKS results” function. Visualisation of the common peptides 168 
released in samples having similar DH but different E:S was then carried out with Venn 169 
diagrams using the venn function (Version 1.7) on Matlab (MathWorks Inc.). Only the 170 
peptides present in βlg variant A were visualised on Venn diagrams. 171 
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2.7 DPP-IV inhibition assay 172 
The hydrolysates were dispersed in MS-grade water, at final concentrations ranging from 3.1 173 
× 10
-2
 to 3.1 mg protein equivalent mL
-1
. The positive control, diprotin A, was assessed at 174 
final concentrations ranging from 12.5 × 10
-2
 and 12.5 µg mL
-1
. The DPP-IV inhibition assay 175 
was carried out as described previously (Nongonierma & FitzGerald, 2013a). Briefly, 25 µL 176 
sample was pipetted in a 96-well clear microplate (Sarstedt, Dublin, Ireland) and mixed with 177 
the reaction substrate, Gly-Pro-pNA (final concentration 0.200 mM). DPP-IV (final 178 
concentration 0.0025 units mL
-1
) was subsequently added to initiate the reaction. The 179 
negative control consisted of 100 mM Tris-HCl buffer pH 8.0 and Gly-Pro-pNA. The 180 
microplate was incubated at 37ºC for 60 min in a microplate reader (Biotek Synergy HT). 181 
The pNA released was measured by monitoring the absorbance at 405 nm. The DPP-IV half 182 
maximal inhibitory concentration (IC50) values were determined by plotting the percentage 183 
inhibition as a function of the concentration of test compound. Each sample was analysed in 184 
triplicate (n=3). 185 
2.8 Statistical analysis 186 
Results were compared by a one way ANOVA with a Tukey’s test at a significance level of p 187 
< 0.05, using R software 3.1.0 (R Foundation for Statistical Computing, Vienna, Austria) and 188 
the Rcmdr library version 2.1-7 package. 189 
3 Results and discussion 190 
3.1 Physicochemical characterisation of βlgH samples 191 
This study investigated the potential impact on hydrolysate properties (peptide release and 192 
DPP-IV inhibition) of altering E:S while still reaching comparable DH values by increasing 193 
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the hydrolysis time during the hydrolysis of βlg with elastase. The range of E:S (i.e., 0.5 to 194 
1.5%) was chosen based on previous studies which have demonstrated the release of DPP-IV 195 
inhibitory peptides during hydrolysis of bovine la with pancreatic elastase at E:S values 196 
ranging from 1.0 to 2.0% (Nongonierma, Le Maux, et al., 2016). In addition, preliminary 197 
experiments were conducted to monitor DH over 180 min during βlg hydrolysis with elastase 198 
at E:S 0.5, 1.0, 1.5 and 2.0% (data not shown). The time required for βlg hydrolysates (βlgH) 199 
to reach a target DH of 9% using an E:S of 0.5, 1.0 and 1.5% (w/w) was 65, 30 and 20 min, 200 
respectively. Furthermore, reaching a target DH of 13% at E:S values of 0.5, 1.0 and 1.5% 201 
(w/v) took 150, 70 and 50 min, respectively (Table 1). 202 
The molecular mass distribution profiles of the βlgH samples are presented in Fig. 1. 203 
Hydrolysis was demonstrated by the breakdown of the high molecular mass components (> 204 
10 kDa) within all the βlgH samples as compared to the βlg-control. All the DH9 samples had 205 
similar molecular mass distributions (p > 0.05). Likewise, all the DH13 samples had similar 206 
molecular mass distributions (p > 0.05). As expected, the DH13 samples had a significantly 207 
lower proportion of large compounds (> 10 kDa) and higher proportion of compounds < 1 208 
kDa compared to all the DH9 samples (p < 0.05). 209 
The E:S employed is a factor known to impact on reaction kinetics (Whitehurst & Law, 210 
2002). In this study, the duration of the hydrolysis reaction required to reach the same DH 211 
was inversely proportional to the E:S as expected. For instance, a βlgH generated with an E:S 212 
of 0.5% needed approximately twice as much time to reach the same DH compared to a βlgH 213 
generated with an E:S of 1% (Table 1). This is in agreement with the effect of enzyme 214 
concentration, as described in the literature, when there are no artefacts present in the system, 215 
i.e., enzyme activators or inhibitors. For instance, Dixon and Webb (1979) stated that for a 216 
given period of time, two enzyme molecules, that act independently, metabolise twice as 217 
much substrate as one enzyme molecule provided the substrate is in excess. 218 
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3.2 Peptide identification in βlgH samples by HILIC-UPLC-MS/MS 219 
The peptides within βlgHs were sequenced using HILIC-UPLC-MS/MS. The protein 220 
coverage for βlg variant A was established by the observation of the peptide signals by 221 
HILIC-MS/MS, using the protein database and without considering the de novo sequencing. 222 
Ninety-eight to hundred per cent of the protein coverage was achieved using these digestion 223 
conditions. The number of peptides identified for βlg variant A ranged from 125 to 169, for 224 
βlgH-0.5-DH13 and βlgH-1-DH9, respectively (Supplementary Tables S1 and S2). Mostly 225 
Lys (> 20%), Leu (> 12.0%), Val (> 8.3%), Glu (> 6.5%), Ile (> 5.7%) and Ala (> 4.6%) 226 
residues were found at the C-terminal sequence of peptides released from βlg by elastase both 227 
at DH 9 and 13% (Fig. 2). 228 
The number of peptides identified, being common or specific to each sample, were presented 229 
using Venn diagrams for each DH value (Fig. 3A and 3B). These show that 62 and 84% of 230 
the peptides were common for the βlgH samples hydrolysed with the three different E:S, for 9 231 
and 13% DH, respectively. The DH9 samples generated at different E:S shared 109 common 232 
peptides (Fig. 3A) whereas the DH13 samples shared 105 common peptides (Fig. 3B). 233 
Samples generated using the same E:S but different DH values had several peptide sequences 234 
in common. For instance, 104, 120 and 106 common peptides were present for samples with 235 
E:S values of 0.5, 1.0 and 1.5%, respectively (data not shown). 236 
Several of the peptides released from βlg by elastase had Ala, Ile, Leu, Val, Ser, Tyr and Thr 237 
residues at their C-terminus (Fig. 2). This is in agreement with the cleavage specificity of 238 
pancreatic elastase (Godfrey, 1996). However, numerous peptides having a Lys or Glu C-239 
terminus were also identified within the βlgHs (Fig. 2). C-terminal Lys residues may be 240 
attributed to the presence of trypsin- or chymotrypsin-like activities (Godfrey, 1996). Trypsin 241 
and chymotrypsin are likely to be present within the porcine elastase preparation used in this 242 
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study as both enzymes together with elastase are secreted by the pancreas. Cleavage at the C 243 
terminal side of Glu residues may arise from the presence of a Glu-specific exopeptidase or a 244 
glutamyl endopeptidase-like activity. The degradation of proteolytic enzymes during the 245 
course of hydrolysis may occur as a consequence of auto-digestion (Hema et al., 2017). The 246 
presupposed presence of numerous enzyme activities within the elastase preparation herein 247 
may suggest that auto-digestion of enzymes may have taken place over the course of the 248 
hydrolytic reaction. However, this was not evaluated within this study. 249 
There was a higher number of common peptides between βlgH-0.5 and βlgH-1, and βlgH-1 250 
and βlgH-1.5 compared to βlgH-0.5 and βlgH-1.5, for both the DH9 and DH13 samples (Fig. 251 
3A and 3B). These differences may be due to enzyme kinetic effects which have been 252 
described elsewhere under other experimental conditions. It had been previously shown that 253 
changes in pH and/or temperature can modify the conformation of the substrate and/or the 254 
enzyme and therefore modify enzyme kinetics (Dixon & Webb, 1979). Cheison et al. (2011) 255 
showed that βlg hydrolysates generated with trypsin at various pH values  7.8 displayed 256 
major differences in peptide composition and also in the kinetics of peptide release. It has 257 
been proposed that enzyme selectivity is a parameter which is more important than the DH to 258 
define the characteristics of a hydrolysate. This is due to the fact that the kinetics of peptide 259 
release may be influenced by factors such as charge (which is pH dependent), temperature, 260 
enzyme active site conformation and its accessibility to the substrate (Butré, Sforza, Gruppen, 261 
& Wierenga, 2014a; Butré, Sforza, Wierenga, & Gruppen, 2015). In addition, substrate 262 
concentration can impact on enzyme selectivity (Butré, Sforza, Gruppen, & Wierenga, 263 
2014b). 264 
A number of hypotheses are proposed to explain the differences in the peptides identified 265 
within the βlgHs as follows: (i) when present within the folded protein, some peptide bonds 266 
may not be accessible to the enzyme; (ii) when peptide bonds are located within a peptide as 267 
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opposed to in a protein, their accessibility to the enzyme may be increased; (iii) when the E:S 268 
is low, the duration of accessibility for peptide bonds is longer and therefore the probability 269 
of cleavage may be increased for peptide bonds for which the enzyme has a high specificity. 270 
In addition, product type inhibition of the enzyme has been reported whereby peptides 271 
released may compete with the protein substrate for binding at the active site of the enzyme, 272 
resulting in slowing down kinetics of protein cleavage (Hema et al., 2017). An earlier study 273 
showed that incubating porcine pancreatic elastase at 50C for 10 min did not alter its activity 274 
whereas < 20% activity remained after exposure of elastase to 65C for 10 min (Ásgeirsson 275 
& Bjarnason, 1993). It is likely that following exposure to temperatures as high as 50C, 276 
elastase may have been thermally denatured over longer incubation times of 20 to 50 min 277 
used herein. 278 
These differences in peptide bond accessibility and modulation of enzyme activity may 279 
explain, for instance, why βlgH-1-DH9 had a substantial number of common peptides with 280 
βlgH-0.5-DH9 and βlgH-1.5-DH9 whereas βlgH-0.5-DH9 and βlgH-1.5-DH9, which have a 281 
greater E:S difference, had a lower number of common peptides (Fig. 3A). As the kinetics of 282 
cleavage of a peptide bond depend of its accessibility, this may explain why a longer 283 
hydrolysis time with less enzyme may yield small differences in peptide profile compared to 284 
a shorter hydrolysis time with a higher enzyme dose. It should also be noted that some 285 
differences observed between the peptide sequences within samples may be attributed to 286 
experimental limitations (i.e., solubility of the peptides during HILIC separation, poor 287 
ionisation of the peptides in the ESI conditions employed) and the data treatment (i.e., poor 288 
identification due to low detection intensity of peptides or poor MS fragmentation spectra). 289 
Therefore, quantitation of the peptides released may be relevant in future studies, particularly 290 
for samples produced under different hydrolysate manufacturing conditions. In addition, 291 
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other modes of separation (e.g., reverse phase or size exclusion chromatography) may be 292 
used in future studies as this could yield additional peptide identification. 293 
3.3 In silico digestion of βlg 294 
Forty peptides ranging between 2 and 9 amino acids were predicted to be released in silico 295 
following the digestion of βlg with elastase (Table 2). Features of DPP-IV inhibitory peptides 296 
were found for 11 of the sequences obtained by the in silico prediction. The sequences 297 
possessing the features of DPP-IV inhibitory peptides varied between 2-6 amino acids. 298 
Among peptides predicted to be released in silico, 16 peptides (Table 2) had previously been 299 
analysed for their in vitro DPP-IV inhibitory activity. One peptide, Trp-Tyr, was shown to 300 
have a DPP-IV IC50 value of 281 µM (Nongonierma & FitzGerald, 2013c). However for the 301 
15 other peptides, the % DPP-IV inhibition observed when tested at 100 µM peptide 302 
concentration were generally low < 22% (Lan et al., 2015) (Table 2). The other peptides > 2 303 
amino acid long with DPP-IV inhibitory peptide features do not appear to have yet been 304 
reported for their DPP-IV inhibitory properties, therefore, their bioactive potential is 305 
unknown. 306 
Significant differences were found between in silico predictions and actual peptides released 307 
as only one of the sequence predicted to be released (Glu-Glu-Gln-Cys-His-Ile) was actually 308 
identified by LC-MS/MS within the βlgHs (Table 2). However, several precursors of the 309 
peptides predicted in silico were identified within the βlgHs (Supplementary Tables S1 and 310 
S2). For example, in the case of the predicted peptide Leu-Ile-Val (βlg (f1-3)), larger 311 
fragments ranging from βlg (f1-6) to βlg (f1-26) and βlg (f1-6) to βlg (f1-23) were identified 312 
within the DH9 and DH13 βlgHs, respectively (Supplementary Tables S1 and S2). 313 
Discrepancies between the peptides predicted to be released and the actual peptides released 314 
indicate that the hydrolysis of βlg was not complete. This was further supported by the 315 
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presence of large material > 10 kDa within all βlgHs (Fig. 1), which corresponded to 316 
unhydrolysed βlg (molecular mass of 18.4 kDa) within these samples. In addition, the 317 
estimated DH for complete digestion of βlg by elastase was 43.5%. This is higher than the 318 
DH values (i.e., 9 and 13%) studied herein. 319 
Previous studies have also reported on significant differences between in silico digestion of 320 
individual proteins and actual peptide release during their in vitro enzymatic digestion. This 321 
was the case for bovine la (Nongonierma, Le Maux, et al., 2016), ovotransferrin (Majumder 322 
& Wu, 2010), potato proteins (Rajendran, Mason, & Udenigwe, 2016) or bovine collagen (Fu 323 
et al., 2016). Analysis of hydrolysates from these proteins showed the presence of larger 324 
peptide fragments comprising the sequences predicted to be released during in silico 325 
digestion. Differences between in silico and in vitro digestion of proteins have mainly been 326 
attributed to the fact that peptide cutters assume that (i) the protein is found as a linear amino 327 
acid sequence (i.e., primary structure) and (ii) digestion of the protein is complete. βLg is a 328 
globular protein which possesses two disulphide bonds, which confer its tertiary structure 329 
(Iametti, Scaglioni, Mazzini, Vecchio, & Bonomi, 1998). This specific structural arrangement 330 
may be responsible for the decreased accessibility of specific peptide bonds within βlg during 331 
enzymatic hydrolysis. For instance, Leeb, Götz, Letzel, Cheison, and Kulozik (2015) 332 
demonstrated the importance of βlg conformation during tryptic hydrolysis on peptide 333 
release. Furthermore, substrate (i.e., ovalbumin) conformation was shown to have a 334 
significant impact on the accessibility of peptide bonds and therefore on the peptides released 335 
(Nyemb et al., 2014). 336 
3.4 DPP-IV inhibitory activity of βlgH samples 337 
As expected, the DPP-IV IC50 values of all the βlgH samples were lower than that of the βlg-338 
control (Table 1). All the DPP-IV IC50 values for the DH9 samples were of the same order (p 339 
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> 0.05) with βlgH-1.5-DH9 having the lowest mean IC50 of 1.35 ± 0.12 mg protein equivalent 340 
mL
-1
. Likewise, all the DH13 samples had IC50 values of the same order (p > 0.05), with the 341 
lowest mean IC50 of 1.02 ± 0.16 mg protein equivalent mL
-1
 for βlgH-0.5-DH13. Generally, 342 
the DH13 samples were significantly more potent than the DH9 samples (p < 0.05), except 343 
for βlgH-1.5-DH9 and βlgH-1-DH13 which were not significantly different from each other 344 
(p > 0.05). 345 
The βlgHs generated herein were relatively potent DPP-IV inhibitors as their DPP-IV IC50 346 
values were comparable to those described in the literature for other whey protein 347 
hydrolysates (Le Maux et al., 2016; Nongonierma & FitzGerald, 2013a). Hydrolysates of βlg 348 
and βlg-derived peptides were previously shown to have in vitro DPP-IV inhibitory activities 349 
(Power, Fernández, Norris, Riera, & FitzGerald, 2014; Silveira, Martínez-Maqueda, Recio, & 350 
Hernández-Ledesma, 2013; Tulipano et al., 2011; Uchida, Ohshiba, & Mogami, 2011). Most 351 
DPP-IV inhibitory peptides reported in the literature appear to possess less than 10 amino 352 
acid residues (Lacroix & Li-Chan, 2016). This is in agreement with this study as βlgH 353 
samples with a higher DH and therefore a greater extent of hydrolysis displayed an increased 354 
DPP-IV inhibitory activity.  355 
The βlgHs contained four known DPP-IV inhibitory peptides which had a moderate DPP-IV 356 
IC50 value > 170 µM (Table 3). Their DPP-IV IC50 values ranged from 174 to 424 µM for 357 
Val-Ala-Gly-Thr-Trp-Tyr and Val-Leu-Val-Leu-Asp-Thr-Asp-Tyr-Lys, respectively 358 
(Silveira et al., 2013; Uchida et al., 2011). Three of these peptides (Val-Ala-Gly-Thr-Trp-Tyr, 359 
Val-Leu-Val-Leu-Asp-Thr-Asp-Tyr-Lys and Thr-Pro-Glu-Val-Asp-Asp-Glu-Ala-Leu-Glu-360 
Lys) were identified within all βlgHs. In contrast, Val-Leu-Asp-Thr-Asp-Tyr was only 361 
identified in βlgH-1-DH13. It is likely that other peptides present within the hydrolysates also 362 
contribute to their overall DPP-IV inhibitory activity. This may be the case for the numerous 363 
peptides possessing the features of DPP-IV inhibitors (i.e., hydrophobic amino acid (Trp, 364 
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Leu, Ile or Phe) at the N-terminus, a Pro/Ala at position 2, and a Pro at the C-terminus 365 
(Nongonierma & FitzGerald, 2013b, 2014; Nongonierma & FitzGerald, 2016; Tulipano et al., 366 
2015a)) which were identified in the βlgHs (Supplementary Table S1 and S2). 367 
4 Conclusions 368 
The strategy of decreasing the E:S while reaching the same DH by increasing the hydrolysis 369 
time for βlg was validated for the generation of bioactive (i.e., DPP-IV inhibitory) 370 
hydrolysates under the conditions studied herein. Even if samples with different E:S but 371 
similar DH could be considered as comparable (molecular mass distribution and DPP-IV IC50 372 
values), some differences were observed at molecular level (i.e., peptides identified). These 373 
differences may be attributed to variations in enzyme kinetics, selectivity and activity which 374 
may depend on the enzyme concentration employed. In addition, while no modifications of 375 
the DPP-IV inhibitory activity of βlgHs having the same DH were seen, this might not be the 376 
case for other bioactive properties or other enzyme-substrate combinations. That is why it 377 
would be of interest to quantify differences in peptides generated under different reaction 378 
conditions. Further studies are required to elucidate the exact role of enzyme concentration on 379 
the kinetics of peptide release and on enzyme selectivity and activity. This could support 380 
selection of the most appropriate parameter(s) that could dictate the optimal conditions to 381 
generate bioactive peptides at least cost. 382 
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Table and Figure captions 537 
 538 
Table 1. Enzyme-to-substrate ratio (E:S), hydrolysis duration, percentage degree of 539 
hydrolysis (%DH), number of identified peptides, half maximal inhibitory concentration 540 
(IC50) for dipeptidyl peptidase IV (DPP-IV) of β-lactoglobulin hydrolysed with elastase 541 
(βlgH) to reach similar DH values under different E:S. The DPP-IV IC50 value of IPI, the 542 
positive control, was of 3.33 ± 0.47 µM. All concentrations in the Table are expressed in 543 
protein equivalent (w/v). Values represent the mean of triplicate determinations ± SD (n = 3). 544 
For each assay, values with different superscript letters are significantly different (P < 0.05). 545 
 546 
Table 2. Peptides predicted to be released following in silico digestion of β-lactoglobulin 547 
(βlg) by elastase. The presence or absence of peptides presenting the features of dipeptidyl 548 
peptidase IV (DPP-IV) inhibitors or sequences identified within a sample was represented by 549 
the signs (+) and (-) respectively. 550 
 551 
Table 3. Sequences of known dipeptidyl peptidase IV (DPP-IV) inhibitory peptides identified 552 
within the β-lactoglobulin hydrolysates (βlgH) generated at degrees of hydrolysis (DH) of 9 553 
and 13% under enzyme-to-substrate ratio (E:S) of 0.5 (βlgH-0.5-DH9; βlgH-0.5-DH13), 1.0 554 
(βlgH-1-DH9; βlgH-1-DH13) and 1.5% (βlgH-1.5-DH9; βlgH-1.5-DH13). Peptides were 555 
analysed by hydrophilic interaction liquid chromatography mass spectrometry (HILIC-556 
UPLC-MS/MS) and then sequenced using PEAKS software. The presence or absence of 557 
sequences identified within a sample was represented by the signs (+) and (-) respectively. 558 
 559 
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Figure 1. Molecular mass distribution determined by gel-permeation ultra-performance 560 
liquid chromatography (GP-UPLC) of β-lactoglobulin (βlg) samples: βlg-control and 561 
hydrolysed βlg (βlgH) under different enzyme-to-substrate ratio (E:S of 0.5, 1.0 and 1.5% 562 
(w/w)) and reaching different degree of hydrolysis (DH9 and DH13). The molecular mass 563 
distribution was determined at 214 nm. BSA, lg, la, aprotinin, bacitracin, Leu-Trp-Met-564 
Arg, Asp-Glu and Tyr were used as standards. Values represent the mean of triplicate 565 
determinations ± SD (n = 3). 566 
 567 
Figure 2. Representation of the occurrence of the C-terminal amino acid residues of the 568 
peptides detected in the β-lactoglobulin hydrolysates (βlgHs) generated at different enzyme-569 
to-substrate ratio (E:S of 0.5, 1.0 and 1.5% (w/w)) and reaching different degree of hydrolysis 570 
(DH) of 9 and 13%. A: alanine; C: cysteine; D: aspartic acid; E: glutamic acid; F: 571 
phenylalanine; G: glycine; H: histidine; I: isoleucine; K: lysine; L: leucine; M: methionine; 572 
N: asparagine; Q: glutamine; R: arginine; S: serine; T: threonine; V: valine; W; tryptophan; 573 
Y: tyrosine. 574 
 575 
Figure 3. Venn diagram visualisation of peptides identified that were common or specific to 576 
hydrolysed βlg (βlgH) to a degree of hydrolysis (DH) of (A) 9 and (B) 13% under enzyme-to-577 
substrate ratio (E:S) of 0.5 (blue), 1.0 (yellow) and 1.5% (w/w) (magenta). Peptides were 578 
analysed by hydrophilic interaction liquid chromatography mass spectrometry (HILIC-579 
UPLC-MS/MS) and then sequenced using PEAKS software. Identified peptides common to 580 
several samples were represented at the intersection of these specific samples. 581 
 582 
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Table 1.  583 
 584 
585 
Sample code E:S 
(%) 
Hydrolysis 
duration (min) 
DH (%) Number of identified 
peptides 
DPP-IV IC50  
(mg mL
-1
) 
βlg-control 0 0 - - > 2 
βlgH-0.5-DH9 0.5 65 9.3 ± 0.3 
a
 146 1.47 ± 0.13 
a
 
βlgH-1-DH9 1.0 30 9.2 ± 0.2 
a
 169 1.49 ± 0.17 
a
 
βlgH-1.5-DH9 1.5 20 9.4 ± 0.2 
a
 136 1.35 ± 0.12 
ab
 
βlgH-0.5-DH13 0.5 150 13.3 ± 0.5 
b
 125 1.02 ± 0.16 
c
 
βlgH-1-DH13 1.0 70 13.0 ± 0.5 
b
 168 1.16 ± 0.15 
bc
 
βlgH-1.5-DH13 1.5 50 13.2 ± 0.1 
b
 147 1.07 ± 0.11 
c
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Table 2.  586 
Peptide sequence* Fragment number** Peptides having 
DPP-IV inhibitory 
features 
DPP-IV 
inhibition*** 
Reference Detected 
by LC-
MS/MS 
LIV f(1-3) +   - 
TQT f(4-6) -   - 
MKGL f(7-10) -   - 
DI f(11-12) -   - 
QKV f(13-15) -   - 
GT f(17-18) - < 5.0 (Lan et al., 2015) - 
WY f(19-20) + 281 (Nongonierma & 
FitzGerald, 2013c) 
- 
MA f(24-25) + 7.1 (Lan et al., 2015) - 
DI f(28-29) -   - 
DA f(33-34) + < 5.0 (Lan et al., 2015) - 
QS f(35-36) - 13.8 (Lan et al., 2015) - 
PL f(38-39) -   - 
RV f(40-41) - < 5.0 (Lan et al., 2015) - 
EEL f(44-46) -   - 
KPT f(47-49) +   - 
PEGDL f(50-54) -   - 
EI f(55-56) - 16.3 (Lan et al., 2015) - 
QKWENDECA f(59-67) -   - 
QKKI f(68-71) -   - 
EKT f(74-76) -   - 
KI f(77-78) - 21.7 (Lan et al., 2015) - 
PA f(79-80) + < 5.0 (Lan et al., 2015) - 
VFKI f(81-84) -   - 
DA f(85-86) + < 5.0 (Lan et al., 2015) - 
NENKV f(88-92) -   - 
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Peptide sequence* Fragment number** Peptides having 
DPP-IV inhibitory 
features 
DPP-IV 
inhibition*** 
Reference Detected 
by LC-
MS/MS 
DT f(96-97) - < 5.0 (Lan et al., 2015) - 
DY f(98-99) - < 5.0 (Lan et al., 2015) - 
KKY f(100-102) -   - 
FCMENS f(105-110) +   - 
EPEQS f(112-116) +   - 
CQCL f(119-122) -   - 
RT f(124-125) - < 5.0 (Lan et al., 2015) - 
PEVDDEA f(126-132) -   - 
EKFDKA f(134-139) -   - 
KA f(138-139), f(141-142) + 5.9 (Lan et al., 2015) - 
PMHI f(144-147) -   - 
RL f(148-149) - 20.2 (Lan et al., 2015) - 
FNPT f(151-154) +   - 
QL f(155-156) - 7.8 (Lan et al., 2015) - 
EEQCHI f(157-162) -   + 
*Peptide sequences abbreviated with the one-letter amino acid code. 587 
**Fragment numbers are provided for the mature sequence of βlg. 588 
***Percentage of DPP-IV inhibition of peptides evaluated at 100 µM by Lan et al. (2015) and DPP-IV IC50 value in µM reported by 589 
Nongonierma and FitzGerald (2013c). 590 
 591 
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Table 3.  592 
Peptide sequence* Fragment 
number** 
βlgH-
0.5-DH9 
βlgH-
1-DH9 
βlgH-1.5-
DH9 
βlgH-0.5-
DH13 
βlgH-1-
DH13 
βlgH-1.5-
DH13 
DPP-IV 
IC50 (µM) 
Reference 
TPEVDDEALEK f(125-135) + + + + + + 319.5 (Silveira et al., 2013) 
VAGTWY f(15-20) + + + + + + 174 (Uchida et al., 2011) 
VLDTDY f(94-99) - - - - + - 471 (Lacroix, Meng, Cheung, & 
Li-Chan, 2016) 
VLVLDTDYK f(92-100) + + + + + + 424.4 (Silveira et al., 2013) 
*Peptide sequences abbreviated with the one-letter amino acid code. 593 
**Fragment numbers are provided for the mature sequence of βlg. 594 
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Figure 1 595 
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Figure 2 597 
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Figure 3 
 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
 
  
DOI: 10.1016/j.foodres.2017.05.012 
 35 
Supplementary data 
Supplementary Table S1. Sequences of peptides identified for the β-lactoglobulin (βlg) variant A within 
hydrolysed βlg samples (βlgH) having a degree of hydrolysis (DH) of 9% under enzyme-to-substrate ratio 
(E:S) of 0.5 (βlgH-0.5-DH9), 1.0 (βlgH-1-DH9) and 1.5% (βlgH-1.5-DH9). Peptides were analysed by 
hydrophilic interaction liquid chromatography mass spectrometry (HILIC-UPLC-MS/MS) and then 
sequenced using PEAKS software. The presence or absence of sequences identified within a sample was 
represented by the signs (+) and (-) respectively. 
Identified peptide sequences* Fragment 
number** 
βlgH-0.5-
DH9 
βlgH-1-
DH9 
βlgH-1.5-
DH9 
AGTWYS f(16-21) + + + 
AGTWYSLA f(16-23) + + + 
ALEKFDK f(132-138) + + - 
ALKALPMHI f(139-147) + + - 
ALKALPMHIR f(139-148) - + - 
ALPMH f(142-146) + - - 
ALPMHIR f(142-148) - + - 
ALPMHIRLSFNPTQLEEQCHI f(142-162) - + + 
AMAASDI f(23-29) + - - 
ASDISLLDAQ f(26-35) + + + 
ASDISLLDAQSAPL f(26-39) + + + 
ASDISLLDAQSAPLR f(26-40) - + + 
ASDISLLDAQSAPLRV f(26-41) + + + 
CMENSAEPEQS f(106-116) + + + 
CMENSAEPEQSLV f(106-118) + + + 
DALNENK f(85-91) + + + 
DALNENKV f(85-92) + + - 
DALNENKVL f(85-93) - + - 
DALNENKVLV f(85-94) + + + 
DALNENKVLVLDT f(85-97) + + + 
DALNENKVLVLDTDYK f(85-100) + + + 
DALNENKVLVLDTDYKK f(85-101) + + + 
DAQSAPLR f(33-40) - + - 
DAQSAPLRV f(33-41) + + + 
DEALEKFDK f(130-138) + - - 
DTDYKK f(96-101) - + + 
EEQCHI f(157-162) + - - 
ELKPTPEGDLEI f(45-56) + - - 
ENSAEPE f(108-114) + + - 
ENSAEPEQS f(108-116) + + + 
ENSAEPEQSLV f(108-118) - + - 
EVDDEALEK f(127-135) + + - 
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Identified peptide sequences* Fragment 
number** 
βlgH-0.5-
DH9 
βlgH-1-
DH9 
βlgH-1.5-
DH9 
EVDDEALEKFDK f(127-138) + + + 
EVDDEALEKFDKA f(127-139) + + + 
FNPTQL f(151-156) + + - 
FNPTQLEEQCH f(151-161) + - - 
FNPTQLEEQCHI f(151-162) + + + 
GDLEILLQ f(52-59) + + - 
GDLEILLQK f(52-60) + + - 
GLDIQKVAGTW f(9-19) + + + 
GLDIQKVAGTWY f(9-20) + + + 
GLDIQKVAGTWYSLA f(9-23) + + + 
GLDIQKVAGTWYSLAMAA f(9-26) + + + 
GLDIQKVAGTWYSLAMAASDISL f(9-31) - + + 
GLDIQKVAGTWYSLAMAASDISLL f(9-32) + + + 
GLDIQKVAGTWYSLAMAASDISLLDAQSAPLRV f(9-41) - + + 
IDALNENKV f(84-92) + - - 
IDALNENKVL f(84-93) + - - 
IDALNENKVLV f(84-94) - + - 
IDALNENKVLVL f(84-95) - - + 
IDALNENKVLVLDT f(84-97) - + + 
IDALNENKVLVLDTDYK f(84-100) + + + 
IDALNENKVLVLDTDYKK f(84-101) + + + 
IIAEKTKIPAVFKI f(71-84) - + - 
IVTQTMK f(2-8) - + + 
KIDALNENK f(83-91) + + + 
KIDALNENKV f(83-92) + + + 
KIDALNENKVLV f(83-94) + + + 
KIDALNENKVLVLDT f(83-97) + + + 
KIDALNENKVLVLDTDYKK f(83-101) + + + 
KVLVLDT f(91-97) + - - 
KVLVLDTDYKK f(91-101) + + + 
KWENDECAQKK f(60-70) + + + 
LFCMEN f(104-109) + + + 
LFCMENSAEPEQS f(104-116) - + - 
LIVTQT f(1-6) + + - 
LIVTQTM f(1-7) + + + 
LIVTQTMK f(1-8) + + + 
LIVTQTMKGLDIQK f(1-14) + + + 
LIVTQTMKGLDIQKV f(1-15) + + + 
LIVTQTMKGLDIQKVAGTWY f(1-20) - - + 
LIVTQTMKGLDIQKVAGTWYSLAMAA f(1-26) - - + 
LKALPM f(140-145) + - - 
LQKWENDECAQ f(58-68) + + - 
LQKWENDECAQK f(58-69) + + + 
LQKWENDECAQKK f(58-70) + + + 
LSFNPTQL f(149-156) + + + 
LSFNPTQLE f(149-157) + + - 
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Identified peptide sequences* Fragment 
number** 
βlgH-0.5-
DH9 
βlgH-1-
DH9 
βlgH-1.5-
DH9 
LSFNPTQLEEQ f(149-159) + + + 
LSFNPTQLEEQC f(149-160) + + + 
LSFNPTQLEEQCHI f(149-162) + + + 
LVLDTDY f(93-99) + + - 
LVLDTDYK f(93-100) + + + 
LVLDTDYKK f(93-101) + + + 
LVRTPEVDDE f(122-131) + + - 
LVRTPEVDDEALEK f(122-135) - + - 
LVRTPEVDDEALEKFDK f(122-138) + + + 
LVRTPEVDDEALEKFDKA f(122-139) + + + 
MENSAEPEQS f(107-116) + + - 
MAASDIS f(24-30) + + + 
MAASDISL f(24-31) + + + 
MAASDISLL f(24-32) + + + 
MAASDISLLDAQ f(24-35) + + + 
MAASDISLLDAQSAPL f(24-39) - + - 
MAASDISLLDAQSAPLR f(24-40) - - + 
MAASDISLLDAQSAPLRV f(24-41) + + + 
MENSAEPEQ f(107-115) + + - 
MENSAEPEQS f(107-116) + + + 
MENSAEPEQSL f(107-117) + + + 
MENSAEPEQSLV f(107-118) + + + 
NENKVLVLDTDYK f(88-100) + + + 
NENKVLVLDTDYKK f(88-101) + + + 
NSAEPEQS f(109-116) + + + 
NSAEPEQSLV f(109-118) - + + 
QLEEQCHI f(155-162) + + + 
RLSFNPTQLEEQ f(148-159) + + + 
RLSFNPTQLEEQCHI f(148-162) + + + 
RTPEVDDEALEK f(124-135) + + + 
RTPEVDDEALEKF f(124-136) + - - 
RTPEVDDEALEKFD f(124-137) - + - 
RTPEVDDEALEKFDK f(124-138) + + + 
RTPEVDDEALEKFDKA f(124-139) + + + 
RVYVEELKPTPE f(40-51) - + - 
RVYVEELKPTPEGDLEIL f(40-57) + + + 
SAEPEQS f(110-116) + + + 
SAEPEQSL f(110-117) + + - 
SDISLLD f(27-33) - - + 
SDISLLDAQ f(27-35) + + + 
SDISLLDAQSAPL f(27-39) + + + 
SDISLLDAQSAPLR f(27-40) + + + 
SDISLLDAQSAPLRV f(27-41) + + + 
SFNPTQL f(150-156) + + + 
SFNPTQLE f(150-157) + + - 
SFNPTQLEEQ f(150-159) + + + 
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Identified peptide sequences* Fragment 
number** 
βlgH-0.5-
DH9 
βlgH-1-
DH9 
βlgH-1.5-
DH9 
SFNPTQLEEQC f(150-160) + + + 
SFNPTQLEEQCH f(150-161) + + + 
SFNPTQLEEQCHI f(150-162) + + + 
SLAMAA f(21-26) - + - 
SLAMAASDISLLDAQSAPLRV f(21-41) - - + 
SLLDAQSAPLR f(30-40) - + + 
SLLDAQSAPLRV f(30-41) - + + 
TKIPAVF f(76-82) + + + 
TKIPAVFK f(76-83) + - - 
TKIPAVFKI f(76-84) - + - 
TKIPAVFKIDALNENK f(76-91) - - + 
TKIPAVFKIDALNENKVLVLDTDYKK f(76-101) - + + 
TPEGDLEIL f(49-57) - + - 
TPEVDDE f(125-131) - + - 
TPEVDDEAL f(125-133) + + - 
TPEVDDEALEK f(125-135) + + + 
TPEVDDEALEKF f(125-136) + + + 
TPEVDDEALEKFD f(125-137) + + + 
TPEVDDEALEKFDK f(125-138) + + + 
TPEVDDEALEKFDKA f(125-139) + + + 
TPEVDDEALEKFDKALK f(125-141) + + + 
TPEVDDEALEKFDKALKALPMHIR f(125-148) + + + 
VAGTW f(15-19) + - - 
VAGTWY f(15-20) + + + 
VAGTWYS f(15-21) + + + 
VAGTWYSLA f(15-23) + + + 
VAGTWYSLAMAA f(15-26) - + + 
VAGTWYSLAMAASDISLLDAQSAPLR f(15-40) - + + 
VAGTWYSLAMAASDISLLDAQSAPLRV f(15-41) - + + 
VDDEALEKFDK f(128-138) + + + 
VEELKPTPE f(43-51) + + + 
VEELKPTPEGDLE f(43-55) + + + 
VEELKPTPEGDLEI f(43-56) + + - 
VEELKPTPEGDLEIL f(43-57) + + + 
VFKIDALNENK f(81-91) - + + 
VFKIDALNENKVLVLDTDYKK f(81-101) - + + 
VLDTDYKK f(94-101) + + + 
VLVLDTD f(92-98) + + + 
VLVLDTDY f(92-99) + + + 
VLVLDTDYK f(92-100) + + + 
VLVLDTDYKK f(92-101) + + + 
VLVLDTDYKKY f(92-102) + + + 
VLVLDTDYKKYLLF f(92-105) - + - 
VRTPEVDDEALEK f(123-135) - + - 
VRTPEVDDEALEKFDK f(123-138) + - + 
VTQTM f(3-7) + - - 
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Identified peptide sequences* Fragment 
number** 
βlgH-0.5-
DH9 
βlgH-1-
DH9 
βlgH-1.5-
DH9 
VYVEELKPTPE f(41-51) + + + 
VYVEELKPTPEGDLE f(41-55) + + + 
VYVEELKPTPEGDLEI f(41-56) - + + 
VYVEELKPTPEGDLEIL f(41-57) + + + 
WENDECAQK f(61-69) + + + 
WENDECAQKK f(61-70) + + + 
WYSLAMAA f(19-26) - - + 
YLLFC f(102-106) + + - 
YLLFCME f(102-108) + + - 
YLLFCMEN f(102-109) + + + 
YLLFCMENSAEPEQS f(102-116) + + + 
YLLFCMENSAEPEQSLV f(102-118) - + - 
YVEELKPTPE f(42-51) + + + 
YVEELKPTPEG f(42-52) - + - 
YVEELKPTPEGD f(42-53) - + + 
YVEELKPTPEGDL f(42-54) + + + 
YVEELKPTPEGDLE f(42-55) + + + 
YVEELKPTPEGDLEI f(42-56) + + + 
YVEELKPTPEGDLEIL f(42-57) + + + 
YVEELKPTPEGDLEILL f(42-58) + + - 
YVEELKPTPEGDLEILLQ f(42-59) + + + 
YVEELKPTPEGDLEILLQK f(42-60) + + + 
*Peptide sequences abbreviated with the one-letter amino acid code. 
**Fragment numbers are provided for the mature sequence of βlg. 
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Supplementary Table S2. Sequences of peptides identified for the β-lactoglobulin (βlg) variant A within 
hydrolysed βlg samples (βlgH) having a degree of hydrolysis (DH) of 13% under enzyme-to-substrate ratio 
(E:S) of 0.5 (βlgH-0.5-DH13), 1.0 (βlgH-1-DH13) and 1.5% (βlgH-1.5-DH13). Peptides were analysed by 
hydrophilic interaction liquid chromatography mass spectrometry (HILIC-UPLC-MS/MS) and then 
sequenced using PEAKS software. The presence or absence of sequences identified within a sample was 
represented by the signs (+) and (-) respectively. 
Identified sequences* Fragment 
number** 
βlgH-0.5-
DH13 
βlgH-1-
DH13 
βlgH-1.5-
DH13 
AASDISL f(25-31) - + - 
AGTWY f(16-20) + + - 
AGTWYS f(16-21) + + + 
ALEKFD f(132-137) + + - 
ALEKFDK f(132-138) + + + 
ALEKFDKA f(132-139) + - - 
ALKALPM f(139-145) - + - 
ALKALPMHI f(139-147) - + - 
ALKALPMHIR f(139-148) + + + 
ALPMHI f(142-147) - + - 
ALPMH f(142-146) - + - 
ALPMHIR f(142-148) - + - 
ALPMHIRLSFNPTQLEEQCHI f(142-162) + + - 
ASDISLLDAQSAPLR f(26-40) - + - 
CMENSAEPE f(106-114) + - - 
CMENSAEPEQS f(106-116) + + + 
DALNEN f(85-90) + + + 
DALNENK f(85-91) + + + 
DALNENKV f(85-92) + + + 
DALNENKVL f(85-93) - - + 
DALNENKVLV f(85-94) + + + 
DALNENKVLVLDTDYK f(85-100) + + + 
DALNENKVLVLDTDYKK f(85-101) + + + 
DAQSAPLRV f(33-41) + + + 
DEALEKFDK f(130-138) + - + 
DTDYKK f(96-101) + + + 
ELKPTPEGDLEI f(45-56) - + - 
ENSAEPE f(108-114) + + + 
ENSAEPEQS f(108-116) + + + 
EVDDEALEK f(127-135) + + + 
EVDDEALEKFDK f(127-138) + + + 
FNPTQL f(151-156) + + + 
FNPTQLEEQ f(151-159) + + + 
FNPTQLEEQCHI f(151-162) + + + 
GDLEILLQ f(52-59) - + + 
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Identified sequences* Fragment 
number** 
βlgH-0.5-
DH13 
βlgH-1-
DH13 
βlgH-1.5-
DH13 
GDLEILLQK f(52-60) + + + 
GLDIQKV f(9-15) + + - 
GLDIQKVAGT f(9-18) + - - 
GLDIQKVAGTW f(9-19) + + - 
GLDIQKVAGTWY f(9-20) + + + 
GLDIQKVAGTWYSLA f(9-23) + + + 
GLDIQKVAGTWYSLAMA f(9-25) - + - 
GLDIQKVAGTWYSLAMAA f(9-26) + + - 
GLDIQKVAGTWYSLAMAASDISL f(9-31) - + - 
GLDIQKVAGTWYSLAMAASDISLL f(9-32) + + - 
GLDIQKVAGTWYSLAMAASDISLLDAQSAPLRV f(9-41) - + - 
IDALNENKV f(84-92) + - - 
IDALNENKVLV f(84-94) + + - 
IDALNENKVLVLDTDYKK f(84-101) + + + 
IVTQTMK f(2-8) + + + 
KIDALNENK f(83-91) + + + 
KIDALNENKV f(83-92) + + + 
KIDALNENKVL f(83-93) + - - 
KIDALNENKVLV f(83-94) + + + 
KIDALNENKVLVL f(83-95) - - + 
KIDALNENKVLVLDT f(83-97) - + + 
KIDALNENKVLVLDTDYKK f(83-101) + + + 
KPTPEGDLEIL f(47-57) + - - 
KVLVLDTDYKK f(91-101) + - + 
KWENDECAQKK f(60-70) + + + 
LDTDYKK f(95-101) - - + 
LFCMEN f(104-109) - + - 
LIVTQT f(1-6) + + + 
LIVTQTM f(1-7) + + + 
LIVTQTMK f(1-8) + + + 
LIVTQTMKGLDIQK f(1-14) + + + 
LIVTQTMKGLDIQKV f(1-15) + + + 
LIVTQTMKGLDIQKVAGTWY f(1-20) - + - 
LIVTQTMKGLDIQKVAGTWYSLA f(1-23) + - - 
LKALPM f(140-145) + + - 
LQKWENDECAQ f(58-68) + + + 
LQKWENDECAQK f(58-69) + + + 
LQKWENDECAQKK f(58-70) + + + 
LRVYVEELKPTPE f(39-51) - - + 
LSFNPTQL f(149-156) + + + 
LSFNPTQLE f(149-157) + - - 
LSFNPTQLEEQ f(149-159) + + + 
LSFNPTQLEEQC f(149-160) + + + 
LSFNPTQLEEQCHI f(149-162) + + + 
LVLDTDY f(93-99) + - + 
LVLDTDYK f(93-100) + + + 
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Identified sequences* Fragment 
number** 
βlgH-0.5-
DH13 
βlgH-1-
DH13 
βlgH-1.5-
DH13 
LVLDTDYKK f(93-101) + + + 
LVRTPEVDDEALEKFDK f(122-138) + + + 
MENSAEPE f(107-114) + - - 
MENSAEPEQS f(107-116) + + - 
MAASDIS f(24-30) + + + 
MAASDISL f(24-31) + + + 
MAASDISLL f(24-32) + + + 
MAASDISLLDAQSAPLRV f(24-41) + + + 
MENSAEPEQ f(107-115) + + + 
MENSAEPEQS f(107-116) + + + 
MENSAEPEQSL f(107-117) + + + 
MENSAEPEQSLV f(107-118) + - + 
NENKVLVLDTDYK f(88-100) + + + 
NENKVLVLDTDYKK f(88-101) + + + 
NPTQL f(152-156) - - + 
NSAEPE f(109-114) + - + 
NSAEPEQS f(109-116) + + + 
NSAEPEQSLV f(109-118) + + + 
QLEEQC f(155-160) + - + 
QLEEQCHI f(155-162) + + + 
RLSFNPTQLEEQ f(148-159) + + + 
RLSFNPTQLEEQCHI f(148-162) + + - 
RTPEVDDEALEK f(124-135) + + + 
RTPEVDDEALEKF f(124-136) - - + 
RTPEVDDEALEKFDK f(124-138) + + + 
SAEPEQS f(110-116) + + + 
SAEPEQSL f(110-117) + + - 
SDISLLD f(27-33) + + - 
SDISLLDAQ f(27-35) - - + 
SDISLLDAQSAPL f(27-39) + + + 
SDISLLDAQSAPLR f(27-40) + + - 
SDISLLDAQSAPLRV f(27-41) + + + 
SFNPT f(150-154) + + - 
SFNPTQL f(150-156) + + + 
SFNPTQLE f(150-157) + - - 
SFNPTQLEEQ f(150-159) + + + 
SFNPTQLEEQC f(150-160) + + + 
SFNPTQLEEQCH f(150-161) + + + 
SFNPTQLEEQCHI f(150-162) + + + 
SLLDAQSAPLRV f(30-41) + + + 
TKIPAV f(76-81) + + + 
TKIPAVF f(76-82) + - + 
TKIPAVFK f(76-83) + + + 
TKIPAVFKIDALNENK f(76-91) - + - 
TPEVDDE f(125-131) + + + 
TPEVDDEA f(125-132) + + + 
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Identified sequences* Fragment 
number** 
βlgH-0.5-
DH13 
βlgH-1-
DH13 
βlgH-1.5-
DH13 
TPEVDDEAL f(125-133) + - - 
TPEVDDEALE f(125-134) + - - 
TPEVDDEALEK f(125-135) + + + 
TPEVDDEALEKF f(125-136) + + + 
TPEVDDEALEKFD f(125-137) + + + 
TPEVDDEALEKFDK f(125-138) + + + 
TPEVDDEALEKFDKA f(125-139) + + + 
TPEVDDEALEKFDKALK f(125-141) + + + 
TPEVDDEALEKFDKALKALPMHIR f(125-148) + + - 
VAGTW f(15-19) + + - 
VAGTWY f(15-20) + + + 
VAGTWYS f(15-21) + + + 
VAGTWYSLA f(15-23) + + + 
VAGTWYSLAMAA f(15-26) + + + 
VAGTWYSLAMAASDISLLDAQSAPLR f(15-40) - + - 
VDDEALEKFDK f(128-138) + + + 
VEELKPTPE f(43-51) + + + 
VEELKPTPEGDLE f(43-55) + + - 
VEELKPTPEGDLEI f(43-56) - + + 
VEELKPTPEGDLEIL f(43-57) + + + 
VFKIDALNENKVLVLDTDYKK f(81-101) + + + 
VLDTDY f(94-99) - + - 
VLDTDYK f(94-100) + + - 
VLDTDYKK f(94-101) + + + 
VLVLDTD f(92-98) + + + 
VLVLDTDY f(92-99) + + + 
VLVLDTDYK f(92-100) + + + 
VLVLDTDYKK f(92-101) + + + 
VLVLDTDYKKY f(92-102) + + + 
VLVLDTDYKKYLLF f(92-105) - + - 
VYVEEL f(41-46) - + - 
VYVEELKPTPE f(41-51) + + + 
VYVEELKPTPEGDLE f(41-55) - + - 
VYVEELKPTPEGDLEIL f(41-57) + + + 
WENDECAQ f(61-68) - - + 
WENDECAQK f(61-69) + + + 
WENDECAQKK f(61-70) + + + 
WYSLAM f(19-24) + + - 
YLLFC f(102-106) + - + 
YLLFCMEN f(102-109) + + + 
YLLFCMENSAEPEQS f(102-116) + - - 
YVEEL f(42-46) + - - 
YVEELKPT f(42-49) + + + 
YVEELKPTPE f(42-51) + + + 
YVEELKPTPEG f(42-52) + - - 
YVEELKPTPEGDL f(42-54) + + + 
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Identified sequences* Fragment 
number** 
βlgH-0.5-
DH13 
βlgH-1-
DH13 
βlgH-1.5-
DH13 
YVEELKPTPEGDLE f(42-55) + + + 
YVEELKPTPEGDLEI f(42-56) + + + 
YVEELKPTPEGDLEIL f(42-57) + + + 
YVEELKPTPEGDLEILL f(42-58) - - + 
YVEELKPTPEGDLEILLQ f(42-59) + + + 
YVEELKPTPEGDLEILLQK f(42-60) + + + 
*Peptide sequences abbreviated with the one-letter amino acid code. 
**Fragment numbers are provided for the mature sequence of βlg. 
 
